TOP

Products
Products

At Gen Re, we believe that information and collaboration are the basis for great innovation.

We leverage the actuarial, medical, and underwriting expertise of our global units with the market-specific knowledge of our regional departments to support your product initiatives.

Our product development support comprises a wide range of services needed by primary insurers, including design of new products, calculation of the respective rates, and development of policy terms and conditions. Post-launch, our portfolio monitoring and experience studies offer additional valuable insights.

Our Products

Card Image

Mortality

Card Image

Longevity

Card Image

Disability

Card Image

Critical Illness/
Dread Disease

Card Image

Health

Card Image

Long Term Care

Our Services

Underwriting

Risk assessment of individual lives is a core strength at Gen Re. We offer services in all areas of risk assessment.

Learn More

Market Research & Surveys

Understand biometric risks – from single portfolios to market-wide surveys.

Learn More

Analytics

Using a wide range of techniques such as random forest, GLMs or neural networks our data scientists get the most of complex data; always in collaborations with our experts from other fields a maximum of insights and interpretability is achieved.

Learn More

Digital Solutions

We help our clients create digital solutions across the insurance value chain.

Learn More

Recent Research

Diabetes and Critical Illness Insurance – Bridging the Protection Gap
Diabetes affects millions and is often undiagnosed. It increases risk for critical illnesses. CI insurance is evolving to support prevention, wellness, and broader coverage – even for prediabetics and diabetics – helping close the protection gap.
Samuel Lim, Winncy Wong
Tropical Diseases Beyond the Tropics? – Dengue, Chikungunya and What Insurers Should Monitor, Not Fear
Dengue and chikungunya, once tropical-only diseases, shows seasonal local transmission in temperate regions due to mosquito spread. Dengue causes mostly acute illness with limited long-term disability, while chikungunya can lead to chronic joint pain. Insurers should monitor but not fear these trends.
Dr. Sebastian Speicher
Warp Speed Engaged – Key Takeaways From the 2025 Next Gen Underwriting Survey & Analytics Report
Sharing insights from our latest Next Gen underwriting survey and analytics report. Learn about workflow trends, the increasing pace of underwriting change, and how Gen Re’s GENIE solution can help you better understand the impacts to mortality slippage.
Frank Chechel, Parag Shah
Reinsurance as a Regulatory Tool
Regulatory frameworks like Solvency II can lead to a focus on compliance at the expense of genuine risk management. The article argues that reinsurance should play a central role in addressing risk, advocating for a stronger focus on substantive accountability rather than regulatory formalism.
Bernhard Wolters
Artificial Intelligence in Medicine – The Future of Shaping Clinical Decision-Making
AI in medicine is rapidly advancing, with scientific interest and FDA-approved devices growing, especially in radiology and cardiology. This article explores AI’s potential in modern healthcare and its implications for the insurance industry.
Dr. Sandra Mitic

Find an Expert in Your Region